Strata Critical Medical (SRTA) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $4.54, +4.61% vs the prior close of $4.34.
- Volume 1.58M shares, 1.9x its 50-day average (heavy).
- New SEC filings: SCHEDULE 13D (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
SRTA jumps 4.6% to $4.54 on 1.9x normal volume. Closed at $4.54, +4.61% vs the prior close of $4.34. Day range $4.50–$4.70, opened at $4.56.
SRTA daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — SRTA jumps 4.6% to $4.54 on 1.9x normal volume
- Closed at $4.54, +4.61% vs the prior close of $4.34. Day range $4.50–$4.70, opened at $4.56.
- Volume was 1.58M shares, 1.9x its 50-day average of 853.25K — unusually heavy trading.
- Price is -15.2% vs its 50-day average ($5.35) and -11.7% vs its 200-day average ($5.14).
- 52-week range $3.95–$6.50; today's close sits at 23% of that range, 30.2% below the 52-week high.
Oct 15, 2026 — SRTA rises 1.4% to $4.34
- Closed at $4.34, +1.40% vs the prior close of $4.28. Day range $4.21–$4.38, opened at $4.29.
- Volume was 917.70K shares, 1.0x its 50-day average of 885.18K.
- Price is -19.2% vs its 50-day average ($5.37) and -15.6% vs its 200-day average ($5.14).
- 52-week range $3.95–$6.50; today's close sits at 15% of that range, 33.2% below the 52-week high.
Oct 14, 2026 — SRTA slides 3.8% to $4.28, a 6-month low
- Closed at $4.28, -3.82% vs the prior close of $4.45. Day range $4.26–$4.44, opened at $4.44.
- Volume was 825.00K shares, 0.9x its 50-day average of 909.87K.
- Price is -20.8% vs its 50-day average ($5.40) and -16.8% vs its 200-day average ($5.15).
- 52-week range $3.95–$6.50; today's close sits at 13% of that range, 34.2% below the 52-week high.
Oct 13, 2026 — SRTA dips 2.0% to $4.45, a 3-month low
- Closed at $4.45, -1.98% vs the prior close of $4.54. Day range $4.45–$4.58, opened at $4.53.
- Volume was 533.70K shares, 0.6x its 50-day average of 929.32K — lighter than usual.
- Price is -18.0% vs its 50-day average ($5.43) and -13.6% vs its 200-day average ($5.15).
- 52-week range $3.95–$6.50; today's close sits at 20% of that range, 31.5% below the 52-week high.
Oct 12, 2026 — SRTA ends flat (+0.2%) to $4.54
- Closed at $4.54, +0.22% vs the prior close of $4.53. Day range $4.45–$4.59, opened at $4.52.
- Volume was 776.10K shares, 0.8x its 50-day average of 929.02K.
- Price is -16.7% vs its 50-day average ($5.45) and -11.9% vs its 200-day average ($5.15).
- 52-week range $3.95–$6.50; today's close sits at 23% of that range, 30.2% below the 52-week high.
Oct 9, 2026 — SRTA rises 1.3% to $4.53
- Closed at $4.53, +1.34% vs the prior close of $4.47. Day range $4.40–$4.58, opened at $4.47.
- Volume was 623.10K shares, 0.7x its 50-day average of 942.98K.
- Price is -17.0% vs its 50-day average ($5.46) and -12.1% vs its 200-day average ($5.15).
- 52-week range $3.95–$6.50; today's close sits at 23% of that range, 30.3% below the 52-week high.
Oct 8, 2026 — SRTA slides 4.5% to $4.47, a 3-month low, 3 down days in a row
- Closed at $4.47, -4.49% vs the prior close of $4.68. Day range $4.45–$4.65, opened at $4.65.
- Volume was 1.14M shares, 1.2x its 50-day average of 943.85K.
- Price is -18.3% vs its 50-day average ($5.47) and -13.3% vs its 200-day average ($5.16).
- 52-week range $3.95–$6.50; today's close sits at 20% of that range, 31.2% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — SRTA dips 1.5% to $4.68, a 3-month low
- Closed at $4.68, -1.47% vs the prior close of $4.75. Day range $4.65–$4.74, opened at $4.74.
- Volume was 703.90K shares, 0.7x its 50-day average of 945.24K.
- Price is -14.6% vs its 50-day average ($5.48) and -9.3% vs its 200-day average ($5.16).
- 52-week range $3.95–$6.50; today's close sits at 29% of that range, 28.0% below the 52-week high.
Oct 6, 2026 — SRTA dips 1.2% to $4.75
- Closed at $4.75, -1.25% vs the prior close of $4.81. Day range $4.72–$4.86, opened at $4.84.
- Volume was 760.50K shares, 0.8x its 50-day average of 955.08K.
- Price is -13.4% vs its 50-day average ($5.49) and -8.0% vs its 200-day average ($5.16).
- 52-week range $3.95–$6.50; today's close sits at 31% of that range, 26.9% below the 52-week high.
Oct 5, 2026 — SRTA rises 1.7% to $4.81
- Closed at $4.81, +1.69% vs the prior close of $4.73. Day range $4.68–$4.91, opened at $4.76.
- Volume was 1.16M shares, 1.2x its 50-day average of 953.36K.
- Price is -12.5% vs its 50-day average ($5.50) and -6.9% vs its 200-day average ($5.16).
- 52-week range $3.95–$6.50; today's close sits at 34% of that range, 26.0% below the 52-week high.
Oct 2, 2026 — SRTA dips 2.1% to $4.73, a 3-month low
- Closed at $4.73, -2.07% vs the prior close of $4.83. Day range $4.71–$4.93, opened at $4.90.
- Volume was 999.60K shares, 1.1x its 50-day average of 946.80K.
- Price is -14.0% vs its 50-day average ($5.50) and -8.5% vs its 200-day average ($5.17).
- 52-week range $3.95–$6.50; today's close sits at 31% of that range, 27.2% below the 52-week high.
SRTA latest news & SEC filings
Every SEC filing by or about SRTA in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form SCHEDULE 13D — Activist-style stake (13D)
Activist-style stake (13D) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 2, 2026 · Form 144 — Planned insider sale
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Tomkiel Melissa M. received an award of 177,858 shares on Sep 24, 2026; now holds 2,244,475
- Tomkiel Melissa M. had withheld for taxes 90,797 shares at $5.27 (≈$478.50K) on Sep 24, 2026; now holds 2,153,678
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 25, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Heyburn William A. received an award of 177,858 shares on Sep 24, 2026; now holds 1,856,206
- Heyburn William A. had withheld for taxes 98,356 shares at $5.27 (≈$518.34K) on Sep 24, 2026; now holds 1,757,850
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 20, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 4, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $72.51M (prior year $45.11M) (+60.7% vs Jun 30, 2025)
- Net income: -$10.52M (prior year -$3.74M) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.12 (prior year -$0.05) (loss widened vs Jun 30, 2025)
Aug 4, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 8, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Things to know before you trade SRTA
- Last results release: Aug 4, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Mar 3, 2026, Nov 10, 2025. Based on that rhythm, the next report is likely around Nov 3, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.10% (largest 5.5%).
- Liquidity: about 878.61K shares (≈$3.99M) trade per day on average.
- 52-week position: $4.54 vs a range of $3.95–$6.50 (23% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 25 sales; latest: Reginald Love sold 5,091 shares on Aug 10, 2026.
- Latest filings: 10-Q Aug 4, 2026; 8-K Aug 4, 2026; 8-K Jun 3, 2026.
- Share count: 88.47M shares outstanding (Jul 28, 2026), +8.3% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Services-Health Services.
SRTA market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 4.56 | 4.70 | 4.50 | 4.54 | 1.58M |
| Oct 15, 2026 | 4.29 | 4.38 | 4.21 | 4.34 | 917.70K |
| Oct 14, 2026 | 4.44 | 4.44 | 4.26 | 4.28 | 825.00K |
| Oct 13, 2026 | 4.53 | 4.58 | 4.45 | 4.45 | 533.70K |
| Oct 12, 2026 | 4.52 | 4.59 | 4.45 | 4.54 | 776.10K |
| Oct 9, 2026 | 4.47 | 4.58 | 4.40 | 4.53 | 623.10K |
| Oct 8, 2026 | 4.65 | 4.65 | 4.45 | 4.47 | 1.14M |
| Oct 7, 2026 | 4.74 | 4.74 | 4.65 | 4.68 | 703.90K |
| Oct 6, 2026 | 4.84 | 4.86 | 4.72 | 4.75 | 760.50K |
| Oct 5, 2026 | 4.76 | 4.91 | 4.68 | 4.81 | 1.16M |
| Oct 2, 2026 | 4.90 | 4.93 | 4.71 | 4.73 | 999.60K |
| Oct 1, 2026 | 5.12 | 5.12 | 4.80 | 4.83 | 1.61M |
| Sep 30, 2026 | 5.13 | 5.18 | 5.08 | 5.11 | 798.30K |
| Sep 29, 2026 | 5.29 | 5.34 | 5.01 | 5.10 | 1.22M |
| Sep 28, 2026 | 5.25 | 5.30 | 5.14 | 5.23 | 654.30K |
| Sep 25, 2026 | 5.28 | 5.40 | 5.20 | 5.33 | 519.60K |
| Sep 24, 2026 | 5.33 | 5.41 | 5.23 | 5.27 | 618.80K |
| Sep 23, 2026 | 5.43 | 5.52 | 5.30 | 5.38 | 895.50K |
| Sep 22, 2026 | 5.46 | 5.50 | 5.33 | 5.48 | 666.30K |
| Sep 21, 2026 | 5.40 | 5.47 | 5.32 | 5.40 | 573.60K |
About Strata Critical Medical
Strata Critical Medical (SRTA) is listed on the Nasdaq and classified by the SEC under “Services-Health Services”. Its business address is in NEW YORK, NY. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1779128.
SRTA board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| William L. Iii Cook | Director | Aug 3, 2026 |
| William A. Heyburn | Co-CEO and CFO | Sep 25, 2026 |
| Andrew Lauck | Director | Aug 3, 2026 |
| Reginald Love | Director | Aug 13, 2026 |
| Edward M Philip | Director | Aug 3, 2026 |
| Melissa M. Tomkiel | Co-CEO and General Counsel | Sep 25, 2026 |
| Robert S Wiesenthal | Director | Aug 3, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Amir Cohen | Chief Accounting Officer | Sep 10, 2026 |
| William A. Heyburn | Co-CEO and CFO | Sep 25, 2026 |
| Melissa M. Tomkiel | Co-CEO and General Counsel | Sep 25, 2026 |
| Louis R. Verdetto | CEO, Clinical Services | Sep 10, 2026 |
| Scott M Wunsch | CEO, Logistics | Sep 10, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 10, 2026 | Reginald Love | Sale | 5,091 | $5.75 |
| Aug 10, 2026 | Reginald Love | Sale | 5,091 | $5.75 |
| Aug 10, 2026 | Reginald Love | Sale | 5,091 | $5.75 |
| Aug 10, 2026 | Reginald Love | Sale | 5,091 | $5.75 |
| Jun 8, 2026 | William A. Heyburn | Sale | 31,671 | $5.87 |
| Jun 8, 2026 | William A. Heyburn | Sale | 31,671 | $5.87 |
| Jun 8, 2026 | William A. Heyburn | Sale | 31,671 | $5.87 |
| Jun 8, 2026 | William A. Heyburn | Sale | 31,671 | $5.87 |
| Jun 8, 2026 | Scott M Wunsch | Sale | 5,550 | $5.87 |
| Jun 8, 2026 | Scott M Wunsch | Sale | 5,550 | $5.87 |
| Jun 8, 2026 | Scott M Wunsch | Sale | 5,550 | $5.87 |
| Jun 8, 2026 | Scott M Wunsch | Sale | 5,550 | $5.87 |
| Jun 8, 2026 | Amir Cohen | Sale | 4,655 | $5.87 |
| Jun 8, 2026 | Amir Cohen | Sale | 4,655 | $5.87 |
| Jun 8, 2026 | Amir Cohen | Sale | 4,655 | $5.87 |
SRTA financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $197.14M | $41.35M | 0.50 | $-48.91M |
| Dec 31, 2024 | $146.82M | $-27.31M | -0.35 | $-2.52M |
| Dec 31, 2023 | $225.18M | $-56.08M | -0.76 | $-32.35M |
| Dec 31, 2022 | $146.12M | $-27.26M | -0.38 | $-37.13M |
| Sep 30, 2021 | $50.53M | $-40.05M | -0.93 | $-15.62M |
Latest balance sheet: total assets $332.70M, total liabilities $53.38M, cash $16.32M (as of Jun 30, 2026).
SRTA earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 4, 2026 | 8-K Item 2.02 (results) | $5.57 |
| May 6, 2026 | 8-K Item 2.02 (results) | $5.33 |
| Mar 3, 2026 | 8-K Item 2.02 (results) | $4.80 |
| Nov 10, 2025 | 8-K Item 2.02 (results) | $4.85 |
| Aug 5, 2025 | 8-K Item 2.02 (results) | $4.16 |
| May 12, 2025 | 8-K Item 2.02 (results) | $3.46 |
| Mar 13, 2025 | 8-K Item 2.02 (results) | $3.03 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $3.49 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Mar 12, 2024 | 8-K Item 2.02 (results) | — |
| Nov 8, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Health Services
GeneDx (WGS)LifeStance Health (LFST)Privia Health (PRVA)Omada Health (OMDA)U S Physical Therapy (USPH)Pennant (PNTG)InnovAge (INNV)EUDA Health (EUDA)DocGo (DCGO)Agape ATP (ATPC)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on SRTA
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.